Press release
Graves' Ophthalmopathy Market to Grow at 8.2% CAGR by 2034
Graves' Ophthalmopathy Market
Graves' ophthalmopathy, also known as thyroid eye disease (TED), is an autoimmune disorder associated with hyperthyroidism and Graves' disease. It is characterized by inflammation and tissue remodeling around the eyes, leading to symptoms such as bulging eyes (exophthalmos), double vision, pain, and, in severe cases, vision impairment.
The disease has a profound impact on patients' quality of life, requiring both systemic and ophthalmic management.
As the prevalence of thyroid-related autoimmune disorders increases globally, the Graves' Ophthalmopathy Market is expanding. Recent therapeutic breakthroughs, particularly the approval of targeted biologics such as Teprotumumab (Tepezza), have revolutionized treatment. With rising awareness, earlier diagnosis, and growing pharmaceutical R&D investments, the market is poised for strong growth through 2034.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/72230
Market Overview
• Market Size (2024): Estimated at USD 1.1 billion
• Forecast (2034): Expected to reach USD 2.5 billion
• CAGR (2024-2034): Projected at 8.2%
Key Growth Drivers
• Rising prevalence of thyroid disorders, particularly Graves' disease.
• Strong demand for biologics and targeted therapies.
• Improved diagnostic capabilities and earlier disease detection.
• Growing collaborations between endocrinologists and ophthalmologists for holistic care.
Key Challenges
• High cost of biologic therapies, limiting accessibility in low-income markets.
• Side effects and long-term safety concerns of immunosuppressants and biologics.
• Limited awareness and delayed diagnosis in developing economies.
• Challenges in integrating multidisciplinary care approaches.
Leading Players
Horizon Therapeutics (Amgen), Roche, Novartis, Sanofi, Teva Pharmaceuticals, AbbVie (Allergan), and research-driven biotech companies exploring new autoimmune and ophthalmic therapies.
Segmentation Analysis
By Treatment Type
• Corticosteroids (Systemic & Local)
• Immunosuppressive Agents
• Biologics (e.g., Teprotumumab, Rituximab, Tocilizumab)
• Orbital Radiotherapy
• Surgical Interventions (Orbital Decompression, Eyelid & Strabismus Surgery)
• Supportive Treatments (Lubricants, Symptomatic Relief)
By Route of Administration
• Oral
• Intravenous
• Subcutaneous
• Topical (Adjunctive)
By Disease Severity
• Mild Graves' Ophthalmopathy
• Moderate-to-Severe Disease
• Sight-Threatening Disease
By End User
• Hospitals
• Specialty Ophthalmology & Endocrinology Clinics
• Ambulatory Surgical Centers
• Academic & Research Institutes
Segmentation Summary
While corticosteroids remain widely used for acute inflammation, biologics such as Teprotumumab have become the fastest-growing treatment option, addressing moderate-to-severe disease with targeted efficacy. Surgical interventions remain essential in advanced cases, while supportive care is vital across all patient groups.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/72230/graves-ophthalmopathy-market
Regional Analysis
North America
• 2024 Market Size: USD 500 million
• 2034 Forecast: USD 1.1 billion
• CAGR: 8.0%
The U.S. dominates with strong biologics adoption, advanced healthcare infrastructure, and high prevalence of autoimmune thyroid disorders.
Europe
• 2024 Market Size: USD 300 million
• 2034 Forecast: USD 680 million
• CAGR: 8.1%
Germany, the U.K., and France lead adoption, supported by reimbursement frameworks and clinical trial activity.
Asia-Pacific
• 2024 Market Size: USD 200 million
• 2034 Forecast: USD 550 million
• CAGR: 9.5%
China, Japan, and India are witnessing rapid growth due to increasing autoimmune disease prevalence and improving access to biologics.
Middle East & Africa
• 2024 Market Size: USD 50 million
• 2034 Forecast: USD 120 million
• CAGR: 8.6%
Saudi Arabia, UAE, and South Africa are expanding endocrine and ophthalmology care facilities, though access to biologics remains limited.
Latin America
• 2024 Market Size: USD 50 million
• 2034 Forecast: USD 120 million
• CAGR: 8.2%
Brazil and Mexico are leading markets, with gradual improvements in autoimmune disease management and biologic adoption.
Regional Summary
North America leads today due to strong biologic adoption, but Asia-Pacific represents the fastest-growing region, with large patient pools and rising healthcare spending.
Market Dynamics
Key Growth Drivers
• Rising incidence of autoimmune thyroid disease fueling patient numbers.
• Increasing clinical validation of biologic therapies for moderate-to-severe cases.
• Expansion of multidisciplinary care models combining endocrinology and ophthalmology.
• Growing awareness campaigns by patient advocacy groups.
Key Challenges
• Accessibility issues due to biologic drug costs.
• Need for long-term safety data on newer therapies.
• Underdiagnosis and mismanagement in emerging markets.
• Variability in treatment protocols across healthcare systems.
Latest Trends
• Rapid adoption of Teprotumumab (Tepezza) as a first-line biologic in the U.S. and Europe.
• Clinical trials evaluating Rituximab and Tocilizumab for refractory cases.
• Research into gene-based and immune-modulating therapies for future treatment.
• Rising demand for personalized medicine and biomarker-driven treatment pathways.
Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72230
Competitor Analysis
Key Companies
• Horizon Therapeutics (Amgen) - Leading with Tepezza, the first FDA-approved biologic for thyroid eye disease.
• Roche - Developing immunotherapy solutions for autoimmune ophthalmic conditions.
• Novartis - Active in ophthalmology and autoimmune drug development.
• Sanofi - Expanding biologics pipeline for inflammatory disorders.
• Teva Pharmaceuticals - Offering corticosteroids and supportive treatments.
• AbbVie (Allergan) - Strong in ophthalmology and immunology products.
• Emerging Biotech Startups - Exploring novel monoclonal antibodies and immune-modulating therapies.
Competitive Dynamics
The market is shifting rapidly from traditional corticosteroids to targeted biologics, with Horizon Therapeutics holding a significant lead. However, competition is expected to intensify as Roche, Novartis, and Sanofi advance their biologic pipelines. Collaborations between biotech startups and larger pharma companies are accelerating innovation.
Conclusion
The Graves' Ophthalmopathy Market is expected to grow from USD 1.1 billion in 2024 to USD 2.5 billion by 2034, at a CAGR of 8.2%.
Opportunities Ahead
• Wider adoption of biologics in Asia-Pacific and emerging markets.
• Expansion of personalized medicine approaches in autoimmune ophthalmology.
• Development of cost-effective biosimilars to increase access.
• Multidisciplinary treatment integration across endocrinology and ophthalmology.
This report is also available in the following languages : Japanese (グレーブス眼症市場), Korean (그레이브스 안과병 시장), Chinese (格雷夫斯眼病市场), French (Marché d'ophtalmopathie de Graves), German (Graves Ophthalmopathie-Markt), and Italian (Mercato dell'oftalmopatia di Graves), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/72230
Our More Reports:
Postmenopausal Osteoporosis Market
https://exactitudeconsultancy.com/reports/72060/postmenopausal-osteoporosis-market
Phosphoglucomutase 1 Deficiency Market
https://exactitudeconsultancy.com/reports/72058/phosphoglucomutase-1-deficiency-market
Maple Syrup Urine Disease Market
https://exactitudeconsultancy.com/reports/72056/maple-syrup-urine-disease-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Graves' Ophthalmopathy Market to Grow at 8.2% CAGR by 2034 here
News-ID: 4192221 • Views: …
More Releases from Exactitude Consultancy
Limbal Stem Cell Deficiency Market to Grow at 9.1% CAGR by 2034
Introduction
Limbal Stem Cell Deficiency (LSCD) is a rare but severe ocular surface disorder caused by the loss or dysfunction of limbal stem cells, which are responsible for maintaining and regenerating the corneal epithelium. Patients with LSCD experience chronic pain, recurrent epithelial breakdown, persistent inflammation, and progressive vision loss. Common causes include chemical burns, severe infections, autoimmune diseases, genetic disorders, and iatrogenic damage from multiple ocular surgeries.
Until recently, corneal transplantation was…
Fuchs' Endothelial Corneal Dystrophy Market to Grow at 7.8% CAGR, Reaching USD 8 …
Introduction
Fuchs' Endothelial Corneal Dystrophy (FECD) is the most common type of corneal endothelial dystrophy, primarily affecting the innermost corneal layer known as the endothelium. Characterized by endothelial cell loss, corneal edema, and vision impairment, FECD often manifests in individuals over the age of 40 and progresses gradually. If left untreated, the condition can cause severe vision loss, requiring corneal transplantation or advanced surgical interventions.
With the global population aging rapidly, FECD…
Intracranial Pressure Monitoring Devices Market will surpass USD 2.5 billion by …
Intracranial Pressure Monitoring Devices Market Outlook 2024-2034: Growth Driven by Rising Neurological Disorders and Technological Advancements
Introduction
Intracranial Pressure (ICP) monitoring devices play a vital role in modern neurology and critical care, enabling the continuous measurement of pressure within the skull. These devices are essential for the management of patients suffering from traumatic brain injuries, hydrocephalus, intracerebral hemorrhages, and other neurological disorders. Over the last decade, the demand for ICP monitoring solutions…
Corneal Endothelial Dystrophy Market to Grow at 7.7% CAGR, Reaching USD 1.1 Bill …
Introduction
Corneal endothelial dystrophy is a progressive eye disorder that affects the inner layer of the cornea, leading to vision impairment due to corneal swelling and scarring. The most common form, Fuchs' endothelial corneal dystrophy (FECD), typically manifests in middle age and progresses with aging, impacting millions globally. If untreated, the condition can lead to severe vision loss requiring corneal transplantation.
As the global population ages and awareness of corneal disorders increases,…
More Releases for USD
Chlorella Market Reach USD 465.85 Million USD by 2030
Market Growth Fueled by Increased Adoption of Plant-Based Proteins and Health Supplements
Global Chlorella Market size was valued at USD 303.75 Mn. in 2023 and the total Chlorella revenue is expected to grow by 6.3 % from 2024 to 2030, reaching nearly USD 465.85 Mn. . The growth of the market is majorly due to increase in the consumer awareness about health, the inclination towards plant-based food such as chlorella and…
Bamboo Clothing Market: USD 1.83B to USD 3.27B by 2030
Bamboo Clothing Market Poised for Robust Growth with Sustainability and Eco-Friendly Trends Driving Demand
The global bamboo clothing market is experiencing substantial growth, spurred by a significant shift towards sustainable fashion and eco-friendly materials. As consumers become increasingly conscious of their environmental impact, bamboo fabric-known for its natural, biodegradable properties-is gaining popularity in the fashion industry. This market is expected to continue its upward trajectory, driven by rising demand for eco-conscious…
Biometrics Market: "Biometrics: USD 34.3B to USD 112.4B by 2031"
Biometrics Market Market Scope:
Key Insights : Biometrics Market size was valued at USD 34.3 billion in 2022 and is poised to grow from USD 39.1 billion in 2023 to USD 112.4 billion by 2031, growing at a CAGR of 14.1% during the forecast period (2024-2031).
Discover Your Competitive Edge with a Free Sample Report :https://www.skyquestt.com/sample-request/biometrics-market
Access the full 2024 Market report for a comprehensive understanding @https://www.skyquestt.com/report/biometrics-market
In-Depth Exploration of the global Biometrics…
Advanced (3D/4D) Visualization Systems Market Size, Trends, Growth, Share to sur …
Fatpos Global has carefully studied specific areas, such as application and product type, in the global Advanced (3D/4D) Visualization Systems Market research study. During the predicted period of 2022 to 2032, each kind gives data on sales. The Advanced (3D/4D) Visualization Systems Market analysis examines into the characteristics and financials of the leading participants.
As per the analysis research report, the Advanced (3D/4D) Visualization Systems Market to…
$100,000,000 USD job contract for travel - $3,000,000 USD referral commission.
Khoja Consultants invites companies, teams or venture capitalists for a $100,000,000 USD contract for travel. The selected company will be providing all accommodations and expenses for a 6-month long business trip around the world. Khoja Consultants expects five-star treatment including close security with private planes, hotels, secured vehicles and helicopters if necessary. More details on the job contract and application are provided at - www.KhojaConsultants.com.
There is a $3,000,000…
IOT Solutions Market worth USD 553.9 million USD by 2026
"The global IoT solutions market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of cybersecurity as a service market for global, Europe, North America, Asia Pacific, South America and Middle East & Africa."
These days many businesses are adopting a market research report…
